![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Karger
E-ISSN: 1660-5535|15|4|270-274
ISSN: 1660-5527
Source: Skin Pharmacology and Physiology, Vol.15, Iss.4, 2002-09, pp. : 270-274
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Cytochrome P450 2. Pharmacogenetics
The Australian Journal of Hospital Pharmacy, Vol. 30, Iss. 3, 2000-06 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Cytochrome P450 1. Multiplicity and Function
The Australian Journal of Hospital Pharmacy, Vol. 30, Iss. 2, 2000-04 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Antiprogestin-Mediated Inactivation of Cytochrome P450 3A4
Pharmacology, Vol. 56, Iss. 3, 1998-02 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Expression and Induction of Cytochrome P450 Isoenzymes in Human Skin Equivalents
Skin Pharmacology and Physiology, Vol. 23, Iss. 1, 2010-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Cytochrome P450 3. Clinically Significant Drug Interactions
The Australian Journal of Hospital Pharmacy, Vol. 30, Iss. 4, 2000-08 ,pp. :